Colibactin causes key cancer mutations

Venture will combine 6 active pharmaceutical ingredient production sites in Europe

Reaction creates actinide 2-metallabiphenylenes

Method provides petroleum-free way to turn industrial biowaste into valuable commodity

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care

Nanotech pioneer aims to pursue grand challenges rather than just write about them

Concerns over the spread of the novel coronavirus leads to decision

The technique, called MicroMapping, identifies potential protein interactions on and between cells

Microbe-specific tracers could help detect infection without relying on inflammation as a surrogate

Graduate student Safia Jilani shares what she learned from this year's conference

#ACSPhilly is one of many scientific conferences postponed or canceled because of concerns over COVID-19

Microbe-specific tracers could help detect infection without relying on inflammation as a surrogate

Tobacco-related compounds probably transported on smokers' clothes and bodies

The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Posters and presentations can be uploaded to SciMeetings starting on March 19

Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

Tearing and cutting lead to measurable debris from various forms of plastic

Current ACS Scholar Rebecca Leuschen chats with this University of Michigan professor about motivation

Strategy reduces volumes and times needed to evaluate CO₂-switchable systems

Chemistry CROs are back in business as rest of world starts to lock down

Some meteorites contain superconducting alloys

Nearly perfect, long-lasting crystalline catalyst turns CO₂ into valuable products

Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

Technology could lessen the environmental impact of 3-D printed buildings by adapting locally harvested soils

Resources are freely available through April 17

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap